New combo therapy aims to shrink sarcomas before surgery
NCT ID NCT05235100
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether giving a targeted drug called Apatinib along with radiation therapy before surgery is safe and effective for people with soft tissue sarcoma in the arms, legs, or trunk. 30 adults took part. The main goal was to see how many had major wound problems within 4 months after surgery. Researchers also tracked side effects, quality of life, and how well the treatment worked.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXTREMITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Radiotherapy Department of Cancer Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100021, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Tumor-Injected drug combo outlast standard care in advanced sarcoma?
- Can light and sound replace X-Rays? a new imaging method aims to see inside without radiation
- Could a condensed radiation course after cervical cancer surgery be just as safe and effective?
- Cancer-Killing virus injected directly into tumors shows promise in Mid-Stage trial
- New drug combo shows promise for rare sarcoma
- New chemo combo shows promise for rare sarcoma